AD

Ann-Marie Duffy

Head Of Data Science & Pharmacovigilance Commercial Strategy at Richmond Pharmacology

Ann-Marie Duffy is an experienced professional currently serving as the Head of Data Science & Pharmacovigilance Commercial Strategy at Richmond Pharmacology since January 2025 and as the Founder & Principal Consultant at EcoLytics.co.uk since May 2024, focusing on tailored data project management with a sustainable approach. Previously, Ann-Marie was the Director of Pharmacovigilance & Clinical Informatics at Research Organisation (KC) Ltd from May 2018 to May 2024, where significant operational efficiencies were achieved. Prior roles include Director of Biometrics & Clinical Monitoring and Head of Clinical Monitoring & Biometrics at St. Stephen's Clinical Research Ltd., and Lead CRA / Acting Clinical Monitoring Manager at The Royal Marsden NHS Foundation Trust. Ann-Marie's educational background includes an MSc Degree in Clinical Research from the University of Liverpool and a Diploma in Health Informatics from the University of Derby.

Links


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Richmond Pharmacology

2 followers

At Richmond, we're on a mission to transform healthcare by delivering faster answers and turning hope into tangible solutions. With over two decades of experience, we've perfected the art of precision, discipline, and innovation in clinical research. Our commitment goes beyond our new name – it's a promise to drive progress, elevate patient care, and break down barriers that stand between patients and life-changing treatments. From innovative trial protocols to leveraging our London location and extensive patient database, we're dedicated to making a real impact. Join us in embracing this exciting change. As Richmond, we're shaping a healthier, brighter future, one breakthrough at a time. Stay connected and follow us for updates on our journey of innovation, healing, and hope. #Richmond #FasterAnswers Specialist services: * Early phase adaptive studies including First-In-Human * Cardiac Safety/Intensive ECG/Thorough QT studies * Ethnic Bridging studies * Early phase patient studies (therapeutic and non-therapeutic). Full service: * Consultancy and Expert Advice * Protocol Writing & CRF Design * Regulatory and Ethics Committee Applications * Healthy Volunteer/Patient Recruitment for Phase I-IV * Clinical Conduct, Pharmacy services * Safety Laboratory and Bioanalytical services * Data Management & Statistics and Report Writing linktr.ee/richmondpharmacology